The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods
18F-Fluorodeoxyglucose has optimal characteristics for use in nuclear medicine and is a priority among radiopharmaceuticals for the diagnosis of cancer by positron emission tomography (PET). 18F-Fluorodeoxyglucose has the longest half-life with the lowest energy of radiation, it allows to obtain PET...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Ukrainian |
| Published: |
The State Expert Center of the Ministry of Health of Ukraine
2018-08-01
|
| Series: | Фармацевтичний журнал |
| Subjects: | |
| Online Access: | https://pharmj.org.ua/index.php/journal/article/view/51/48 |